Clinical trial
A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the…
NCT00250432 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00250432 |
|---|---|
| Title | A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) |
| Official title | A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of Caspofungin in the Treatment of Invasive Candidiasis in Adults |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Invasive Candidiasis |
| Intervention type | Drug |
| Interventions | caspofungin acetate |
| Enrollment | 204 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Nov 8, 2005 |
| Last update posted | Mar 24, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: